Extending value long after the clinical trial with real-world data
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the pharmaceutical life cycle. We have already reviewed how RWD can accelerate the path to regulatory approval by leveraging it before a clinical trial even ...